Gentel is in the process of making substantial investments in additional instrumentation to aggressively expand the capacity of the company in direct response to ongoing and new client contracts.
Gentel Biosciences has expanded the Custom Services organisation beginning with an intial investment in multiple Tecan automated systems to meet the growing demands in sample testing and custom assay development for multipex protein measurements.
The additional equipment has enabled Gentel to automate and process thousands more samples per day for its growing list of clients, including a number of biotechnology companies and academic research centers.
"These investments play an important role in continuing the commercial and technical expansion of Gentel.
"Gentel is in the process of aggessively expanding our bandwidth in building products, executing contract research and offering a service platform for commercial growth.
"Tecan continues to play an important role as a trusted corporate provider.
"They demonstrate corporate excellence in providing valuable tools for the advancement of life sciences", says Randall Durnell, Gentel's VP of commercial operations.
Gentel combines its proprietary protein microarray technology, substantial expertise in array development and processing with Tecan systems to yield a reliable, highthroughput platform for multiplex protein analysis.
